Yemaachi Biotechnology is a biotech company that diversifies and expands access to precision cancer diagnostics and therapeutics. It achieves this by collecting and sequencing samples from African populations, which represent the most genetically diverse population on Earth, to build a unique clinical and molecular knowledgebase.
Yemaachi Biotechnology was founded by the Yemaachi Biotechnology Team. The organization operates as a launched startup and is part of the Y Combinator community.
The company addresses the lack of diversity in genomic research, where African populations are often underrepresented despite having the highest genetic diversity. Yemaachi Biotechnology uses African genetic data to optimize existing cancer diagnostic tests and help other companies discover new ones that are effective for a broader range of people.
Yemaachi Biotechnology is based in San Francisco, CA, and operates with a remote-friendly policy. However, its primary research activities are conducted in Africa to leverage direct access to the continent's diverse genetic pool.
Yemaachi Biotechnology provides a first-of-its-kind clinical and molecular knowledgebase on cancer among African people. This data is used for precision diagnostics, the optimization of therapeutic tests, and assisting partner companies in the discovery of new medical treatments.